Targeting dendritic cell metabolism in cancer

Nature Medicine

Volumn 16, Issue 8, 2010, Pages 858-859

  Zitvogel, Laurence ^a   Kroemer, Guido ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 FUROIC ACID DERIVATIVE; 5 (TETRADECYCLOXY) 2 FUROIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

BREAST CARCINOMA; CANCER IMMUNOTHERAPY; CELL METABOLISM; CELLULAR IMMUNITY; COLON CARCINOMA; DENDRITIC CELL; HOST; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IN VIVO STUDY; INNATE IMMUNITY; MELANOMA; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; T CELL LYMPHOMA; THYMOMA; TRIACYLGLYCEROL BLOOD LEVEL; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; DENDRITIC CELLS; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNITY, INNATE; IMMUNOTHERAPY; MICE; MODELS, BIOLOGICAL; NEOPLASMS; TUMOR ESCAPE;

EID: 77955409123     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0810-858     Document Type: Short Survey

References (12)

1. Smyth M.J., Dunn G.P., Schreiber R.D. Adv. Immunol. 90. 1-50 (2006).
2. Zitvogel, L., Tesniere, A. & Kroemer, G. Nat. Rev. Immunol. 6, 715-727 (2006).
3. Zitvogel, L. et al. J. Clin. Invest. 118, 1991-2001 (2008).
4. Herber, D.L. et al. Nat. Med. 16, 880-886 (2010).
5. Steinman, R.M. & Banchereau, J. Nature 449, 419-426 (2007).
6. Yi, H. et al. Blood 113, 5819-5828 (2009).
7. Beckers, A. et al. Cancer Res. 67, 8180-8187 (2007).
8. Menendez, J.A. & Lupu, R. Nat. Rev. Cancer 7, 763-777 (2007).
9. Little, J.L., Wheeler, F.B., Fels, D.R., Koumenis, C. &Kridel, S.J. Cancer Res. 67, 1262-1269 (2007).
10. Panaretakis, T. et al. Cell Death Differ. 15, 1499-1509 (2008).
11. Ramakrishnan, R. et al. J. Clin. Invest. 120, 1111-1124 (2010).
12. Zitvogel, L., Apetoh, L., Ghiringhelli, F. & Kroemer, G. Nat. Rev. Immunol. 8, 59-73 (2008).